Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunshan Longdeng Reedy Pharmaceutical is a prominent joint venture between the Indian pharmaceutical giant Dr. Reddy's Laboratories and the Rotam Group. Established in 2000 and based in Kunshan, China, the company specializes in the manufacturing, marketing, and distribution of high-quality generic pharmaceutical products for the Chinese market. Its product portfolio primarily focuses on therapeutic areas such as cardiovascular health, gastroenterology, and anti-infectives, featuring essential medications like amlodipine and omeprazole. The company operates a state-of-the-art, GMP-certified manufacturing facility that adheres to international quality standards. By combining Dr. Reddy's global R&D capabilities with Rotam's local expertise, the company has become a key player in providing affordable healthcare solutions across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunshan Longdeng Reedy Pharmaceutical.